København S, Denmark

Jørgen Eskildsen

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • København S, DK (2013 - 2015)
  • København, DK (2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jørgen Eskildsen: Innovator in Therapeutic Compounds

Introduction

Jørgen Eskildsen is a notable inventor based in København S, Denmark. He has made significant contributions to the field of therapeutic compounds, particularly in the area of nicotinic acetylcholine receptors. With a total of 4 patents to his name, his work has the potential to impact various medical treatments.

Latest Patents

Eskildsen's latest patents focus on positive allosteric modulators of the nicotinic acetylcholine receptor. These inventions relate to compounds that are useful in therapy, compositions comprising these compounds, and methods for treating diseases through their administration. The compounds he has developed are specifically positive allosteric modulators (PAMs) of the nicotinic acetylcholine α7 receptor, which are crucial for advancing therapeutic options.

Career Highlights

Jørgen Eskildsen is currently associated with H. Lundbeck A/S, a company renowned for its focus on brain diseases. His work at Lundbeck has allowed him to explore innovative solutions in the pharmaceutical industry, contributing to the development of new therapies.

Collaborations

Eskildsen has collaborated with notable colleagues, including Anette Graven Sams and Ask Püschl. These partnerships have fostered a collaborative environment that enhances the research and development of therapeutic compounds.

Conclusion

Jørgen Eskildsen's contributions to the field of therapeutic compounds, particularly through his patents on positive allosteric modulators, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…